S., Manova, K., Barlas, A., et al
Silence Therapeutics plc Verve Therapeutics NewAmsterdam Pharma Corporation Sciwind Biosciences #CardiometabolicTherapeutics #HealthcareInnovation #InsightAce To view or add a comment, sign in Drug Discovery Digest | This Weeks Industry Roundup Obesity, Prediction Markets & The Future of R&D Discovery on Target 2026 is comingregister by June 12 to take advantage of the next savings deadline: Here are four developments shaping the future of drug discovery and development Science & Clinical Updates The Next Wave of Obesity Drug Readouts Is Here With multiple companies racing to compete in the obesity market, recent clinical updates from Pfizer, Lilly, and Viking are helping define the next generation of weight-loss therapies and differentiation strategies
That might mean a small calorie reduction, more steps, better tracking accuracy, improved protein consistency, or a conversation with your provider
Common side effects include nausea, diarrhea, constipation, vomiting and indigestion
Some companies, such as Mochi Health, require patients to meet virtually with a provider, such as a doctor, nurse practitioner or physician assistant, before they can get a GLP-1 prescription